Real-time enrollment status for this breast cancer clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 2:13 AM UTC
| NCT Number | NCT06590857 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 124 participants |
| Active Locations | 23 sites in the US |
| Sponsor | RayzeBio, Inc. |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of April 17, 2026: Clinical trial NCT06590857 is currently active_not_recruiting participants. This clinical trial study for breast cancer is not currently accepting new participants at 23 locations across the United States. The study is sponsored by RayzeBio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06590857 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06590857 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.